paraneoplastic neurological syndromes
GPTKB entity
Statements (93)
Predicate | Object |
---|---|
gptkbp:instanceOf |
paraneoplastic syndrome
neurological syndrome |
gptkbp:affects |
gptkb:skeletal_muscle
gptkb:nervous_system central nervous system peripheral nervous system neuromuscular junction |
gptkbp:associatedWith |
gptkb:cancer
leukemia Small Cell Lung Cancer autoimmune response |
gptkbp:cause |
neurological symptoms
|
gptkbp:diagnosedBy |
MRI
antibody testing CSF analysis |
https://www.w3.org/2000/01/rdf-schema#label |
paraneoplastic neurological syndromes
|
gptkbp:mayInclude |
gptkb:Lambert-Eaton_myasthenic_syndrome
gptkb:opsoclonus-myoclonus_syndrome gptkb:paraneoplastic_cerebellar_degeneration stiff-person syndrome paraneoplastic limbic encephalitis subacute sensory neuropathy |
gptkbp:symptom |
gptkb:dementia
gptkb:depression gptkb:orthostatic_hypotension gptkb:encephalopathy gptkb:Babinski_sign confusion fever memory loss nystagmus pain anxiety anorexia constipation fatigue headache muscle stiffness rigidity tremor muscle pain weight loss muscle atrophy muscle twitching muscle weakness spasticity apathy peripheral neuropathy seizures autonomic dysfunction night sweats ataxia dysautonomia hallucinations sleep disturbance muscle cramps dry mouth urinary retention erectile dysfunction fasciculations gait disturbance parkinsonism ptosis vertigo dysphagia personality change psychiatric symptoms myoclonus muscle wasting sensory loss visual disturbances diplopia dysarthria paresthesia dry eyes hyperreflexia incontinence muscle hypertrophy speech disturbance dysesthesia hyporeflexia muscle fasciculations muscle tenderness sweating abnormalities |
gptkbp:treatment |
gptkb:cancer
gptkb:IVIG immunotherapy corticosteroids plasmapheresis |
gptkbp:bfsParent |
gptkb:DRP2
gptkb:NXP-1 gptkb:SOX1 |
gptkbp:bfsLayer |
7
|